Category: Imaging & mpMRI

We’ve all heard the saying that no news is good news. It’s meant to be reassuring in the face of worry over an unknown outcome. The news must not be bad, because you would have heard if it were. When it comes to using multiparametric MRI (mpMRI) for Active Surveillance (AS) monitoring, a negative scan keep reading

Did you ever shop for a dozen eggs and open the carton to make sure none are cracked? After assessing they’re all intact, that’s as far as your inspection goes. Now imagine you had x-ray vision, and you could see all 12 yolks in their 3-dimensional glory. You would know if each egg is perfect, keep reading

The seven bullet points in the original blog below have stood the test of time since we first reported them in 2016. Four years later, the journal Nature published an article by some of the world’s experts in the use of multiparametric MRI (mpMRI). Compare their 6 key points with... keep reading

Multiparametric MRI (mpMRI) is a simple, elegant way for men suspected of prostate cancer (PCa) to avoid an unnecessary biopsy. It’s especially beneficial in making treatment decisions that match the patient’s disease and its extent. And, for patients who are facing radical prostatectomy (RP), mpMRI can improve surgical outcomes by ruling out positive surgical margins. keep reading

Can you imagine having a PSA higher than 100–four prostate biopsies don’t find cancer? This is the true story of a 73-year old man who came to Duke University Medical Center early in 2021. When he was examined, his prostate gland was... keep reading

Your PSA blood test came back abnormally high. Your doctor says you might have prostate cancer (PCa) and wants to do a needle biopsy, but guess what? You have a choice. Either: a) He numbs you up and pokes your prostate gland with needles in order to extract tissue samples, or b) He sends you keep reading

Multiparametric MRI (mpMRI) has been the biggest gamechanger in the prostate cancer world for the past 15 years. It has revolutionized not only the detection prostate cancer (PCa), but it can actually fine tune the diagnosis, treatment plan, and even the treatment itself. Traditionally, almost all aspects of PCa were within the specialty of urology, keep reading

The title is a bit of a trick question. MRI can’t “see” actual genes or prostate cancer gene mutations. There are indeed genetic factors that contribute to both the risk of developing prostate cancer (PCa), and the behavior of particular cell lines. Ongoing research continues to shed light on the genomics of prostate cancer, and keep reading

PSMA-PET scans have become the most sensitive prostate cancer (PCa) detection for metastasis (cancer that has spread to other parts of the body), including recurrent PCa after treatment. PET uses a radioactive tracer that has been molecularly bonded with a substance readily taken up by prostate specific membrane antigen (PSMA). keep reading

There’s an unfounded rumor floating around that Artificial Intelligence (AI) may one day replace radiologists. As a specialty field in medicine, the field is based in imaging, which allows the diagnosis and treatment of injuries and diseases. Today’s imaging techniques include X-rays, computed tomography (CT), positron emission tomography (PET), ultrasound (US) and magnetic resonance imaging keep reading